Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-11

Clinical Trial Update: REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (RESPONSE) is evaluating a reduced-dose steroid protocol for childhood nephrotic syndrome and is currently recruiting at multiple sites…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroids (corticosteroids)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Nephrotic Syndrome in Children, Nephrotic Syndrome, Minimal Change | Phase 3 | Status: RECRUITING